SPONSOR
Qifu Li
Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: Endocrine DiseaseMetabolic DisordersHypertensionDiabetes MellitusPrimary AldosteronismAutonomous Cortisol Secretion
Qifu Li is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Endocrine Disease, Metabolic Disorders, Hypertension, Diabetes Mellitus.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Qifu Li
How many clinical trials has Qifu Li sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Qifu Li, of which 2 are actively recruiting participants. These trials cover conditions including Endocrine Disease, Metabolic Disorders, Hypertension. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Qifu Li research focus on?
Qifu Li clinical trials span Endocrine Disease, Metabolic Disorders, Hypertension, Diabetes Mellitus, Primary Aldosteronism, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Qifu Li clinical trial?
To participate in a Qifu Li trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Qifu Li trials with current recruitment status updated daily.
Clinical Trials by Qifu Li
NCT07512609
Recruiting
Environment, Inflammation and Metabolic Diseases Study
Endocrine Disease
NCT06833437
Recruiting
68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Diagnosing Unilateral Subtype of Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion (PREDICT)
Primary Aldosteronism
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology